Skip to content
Open access

Transcatheter Potts Shunt in Pulmonary Arterial Hypertension After Patent Ductus Arteriosus Closure

Oct 2026 · Pulmonary Circulation · Vol 16 · 0 citations · 8 references
Medicine

TL;DR

This case achieved short‐term recovery of cardiac function and long‐term maintenance of pulmonary vascular stability and demonstrates that the transcatheter Potts shunt is a feasible and effective life‐prolonging treatment option for severe PAH, even in patients with a history of prior PDA closure.

Abstract

ABSTRACT We report the case of an 18‐year‐old female with progressive, end‐stage pulmonary arterial hypertension (PAH) despite receiving maximal triple combination therapy. The patient had a history of patent ductus arteriosus (PDA) closure at 15 months of age. Due to a pulmonary hypertensive crisis during anesthesia induction, a transcatheter Potts procedure was successfully performed under extracorporeal membrane oxygenation (ECMO) support, involving covered stent implantation just below the previous PDA occluder. At the 3‐month follow‐up, the patient demonstrated significant clinical improvement, shifting to WHO class II–III, with a dramatic decrease in NT‐proBNP (5406–512 pg/ml) and an increased 6‐min walk distance (< 300 to 390 m). This case achieved short‐term recovery of cardiac function and long‐term maintenance of pulmonary vascular stability and demonstrates that the transcatheter Potts shunt is a feasible and effective life‐prolonging treatment option for severe PAH, even in patients with a history of prior PDA closure.

Read PDF

Similar papers

Open access Oct 2026

Salvage Use of Sotatercept for Potts Shunt in Refractory Pulmonary Hypertension

It is suggested that short‐term perioperative sotatercept can serve as an effective acute rescue therapy to safeguard high‐risk surgical interventions in critical pediatric PAH.

Zhuo-Yuan Xu, Ming-Jie Zhang, Yi-Wei Chen et al. · 0 citations
Review Open access Oct 2026

Early outcomes of reversed potts shunt in pediatric pulmonary arterial hypertension

Pediatric pulmonary arterial hypertension carries a poor prognosis. Reversed Potts shunt has been proposed as a bridge from medical therapy to lung transplantation, yet evidence supporting its ability to preserve right ventricular function and improve symptoms in this population remains limited. Pediatric...

X. Lin, J. Yuan, M. Zeng et al. · 0 citations
Open access Oct 2026

Pulmonary Artery Denervation for Persistent Pulmonary Hypertension After Transcatheter Mitral Edge‐to‐Edge Repair: A Pilot Study and First Application in the Post M‐TEER Setting

ABSTRACT Pulmonary hypertension (PH) is common in patients undergoing transcatheter mitral edge‐to‐edge repair (M‐TEER) and is an established determinant of adverse outcomes after intervention. Importantly, persistent PH after technically successful M‐TEER remains associated with ongoing symptoms, right ventricular dys...

Xiang Chen, Ze-Ying Zhang, Xiao-Ying Lan et al. · 0 citations
Review Sep 2026

Management of Patent Ductus Arteriosus in the Adult Population.

This review covers the management of PDA in adults, highlighting the pathophysiology, morphological classification, clinical presentation, and current approaches to closure, with transcatheter closure currently the preferred approach.

Anthony J. Kaywood, Alishah Ahmadi, W. Frishman · 0 citations
Open access Oct 2026

Aorto-Pulmonary Shunt Creation in Congenital Heart Disease: Different Indications, Various Modifications, but Common Technical Challenges.

Percutaneous creation of an aorto-pulmonary (AP) shunt has been explored in preclinical models for over 15 years, yet its clinical application remains limited. Surgical AP shunts are widely used to augment pulmonary blood flow in cyanotic congenital heart disease, but repeated thoracic operations and general anesthesia...

Matija Bakoš, S. Georgiev, Kerstin Wustman et al. · 0 citations
Case report Open access Oct 2026

Severe Obstructive Pan-Leaflet Thrombosis After Transcatheter Aortic Valve Replacement.

BACKGROUND Bioprosthetic valve thrombosis is an uncommon but important cause of late bioprosthetic valve dysfunction after transcatheter aortic valve replacement (TAVR). CASE SUMMARY An 82-year-old man with a history of TAVR presented with worsening exertional dyspnea and orthostasis after recent left atrial appendag...

Peng-Ang Song, Jason Samii, Shawn McKissick et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.